HIV p17
Reaktivität: Human Immunodeficiency Virus (HIV)
ELISA, WB
Wirt: Maus
Monoclonal
unconjugated
Applikationshinweise
ELISA: 1:500-1:1000, WB 1:500-1:1000 Optimal conditions should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Konzentration
Lot specific
Buffer
Suppliedin lyophilized form in50 mM Tris buffer, pH 8.0
Handhabung
Avoid repeated freeze/thaw cycles. Use of Sodium Azide will inhibit enzyme activity of horseradish peroxidase. Dilute only prior to immediate use.
Lagerung
4 °C/-80 °C
Informationen zur Lagerung
Store lyophilized format 4 °C. Store frozen product at -70 °C.
Target
HIV p17
(Human Immunodeficiency Virus Matrix (HIV p17))
Andere Bezeichnung
HIV Gag p17
Substanzklasse
Viral Protein
Hintergrund
The p17 matrix protein, one of the products of the HIV gag gene, serves a structural function inside mature HIV particles. Units of p17 line the inside of the HIV envelope, helping to anchor the gp41/gp120 spikes to the envelope. Once the HIV core has entered the cell, p17 also serves the function of helping it be transferred into the cell's nucleus. It achieves this because it carries nuclear localisation signals (sequences of protein which are recognised by cellular machinery as indicating that it should be transported into the nucleus). Synonyms: Polyclonal HIV1 p17 antibody, Anti-HIV1 p17 antibody, HIV-1 p17 antibody, p17 antibody, HIV 1 p17 antibody, Human Immunodeficiency Virus 1 antibody, HIV1 matrix antibody p17 antibody, MA antibody, Matrix antibody p17 antibody, HRP conjugated HIV1 p17 antibody.